¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"blood group substance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • blood flow
    1. Ç÷·ù 2. Ç÷·ù·®
  • blood flow meter
    Ç÷·ù°è
  • blood flow rate
    1. Ç÷·ù·® 2. Ç÷·ù¼Óµµ
  • blood fluke
    ÁÖÇ÷ÈíÃæ
  • blood gas
    Ç÷¾×°¡½º
  • blood gas apparatus
    Ç÷¾×°¡½ººÐ¼®ÀåÄ¡
  • blood gas solubility coefficient
    Ç÷¾×°¡½º¿ëÇØ°è¼ö
  • blood glucose
    Ç÷´ç
  • blood glucose monitoring
    Ç÷´ç°¨½Ã
  • blood grouping
    Ç÷¾×Çü°Ë»ç
  • blood line
    Ç÷Á·°è, Ç÷Åë
  • blood loss
    ½ÇÇ÷, Ç÷¾×»ó½Ç
  • blood mole
    Ç÷¾×±âÅÂ
  • blood plasma
    Ç÷Àå
  • blood pool scan
    Ç÷¾×¿õµ¢À̽ºÄµ, Ç÷¾×Àú·ù½ºÄµ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • postacrosomal substance
    ÷´ÜüµÚ¹°Áú
  • pressor substance
    Ç÷¾Ð»ó½Â¹°Áú
  • pyrogenic substance
    ¹ß¿­¹°Áú
  • radioactive substance
    ¹æ»ç¼±¹°Áú
  • radiomimetic substance
    ¹æ»ç¼±À¯»çÀÛ¿ë¹°Áú
  • reaction substance
    ¹ÝÀÀ¹°Áú
  • receptive substance
    ¼ö¿ë¹°Áú
  • reducing substance
    ȯ¿ø¹°Áú
  • released substance
    ¹æÃâ¹°Áú
  • reserve substance
    ÀúÀå¹°Áú
  • reticular substance
    ±×¹°±¸¼º¹°Áú
  • substance
    ¹°Áú, Áú
  • sleep-promoting substance
    ¼ö¸éÁõÁø¹°Áú
  • slow-reacting substance
    Áö¿¬¹ÝÀÀ¹°Áú
  • specific soluble substance
    ƯÀ̰¡¿ë¹°Áú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • red blood cell destruction
    ÀûÇ÷±¸ºØ±«(îåúìϹÝÚÎÕ)
  • red blood cell pasta
    ÀûÇ÷±¸È£Á¦(¡­ûÕð¥).
  • red blood cell survival test
    ÀûÇ÷±¸¼ö¸í½ÃÇè(îåúìϹáøÙ¤ãËúÐ).
  • red blood cell=RBC
    ÀûÇ÷±¸
  • red blood corpuscle
    ÀûÇ÷±¸.
  • regenerated blood
    Àç»ýÇ÷¾×(î¢ßæúìäû).
  • regenerated blood
    Àç»ýÇ÷¾×(Àç»ýÇ÷¾×).
  • renal blood flow
    ½ÅÇ÷·ù·®
  • renal blood flow =RBF
    ½ÅÇ÷·ù(·®)(ãìúìêüåÖ).
  • renal blood vessel
    ÄáÆÏÇ÷°ü
  • Coxsackie group A
    ÄÛ»èŰ A±º.
  • Coxsackie group B
    ÄÛ»èŰ B±º.
  • GCR= group conformity rating
    Áý´ÜÇÕÄ¡ µî±ÞºÐ·ù.
  • Gag => group specifiic antigen/core
    ±×·ì<±º>ƯÀ̼º Ç׿ø/ÄÚ¾î
  • amino group
    ¾Æ¹Ì³ë±â(¡­Ðñ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • psittacosis-lymphogranuloma-trachoma (PLT) group
    PLT±º Ŭ¶ó¹Ìµð¾Æ
  • psittacosis-lymphogranuloma-trachoma group
    ¾Þ¹«(»õ)º´ ¸²ÇÁÀ°¾ÆÁ¾Áõ Æ®¶óÄÚ¸¶±º(¡­ë¿ä´ðþñø¡­ÏØ).
  • psittacosis-lymphogranuloma-trachoma group
    ¾Þ¹«(»õ)º´(¡­Ü») ¸²ÇÁÀ°¾ÆÁ¾Áõ Æ®¶óÄÚ¸¶±º(¡­ë¿ä´ðþñø¡­ÏØ)
  • psychotherapy, group
    Áý´ÜÁ¤½ÅÄ¡·á.
  • self-help group
    ÀÚÁ¶Áý´Ü
  • sensitivity groups, as group therapy
    ¹Î°¨¹ÝÀÀ±º(Áý´ÜÄ¡·á)
  • sinus group, anterior
    ÀüºÎºñµ¿±º
  • solvable group
    °¡¿ëÇØ±º(ʦéÁú°ÏØ).
  • streptococcus, viridans [group]
    ¾ËÆÄ[³ì»ö]¿ëÇ÷ ¿¬¼â±¸±Õ[±º]
  • symmetry group
    ´ëαº(ÓßöàÏØ).
  • taxonomic group
    ºÐ·ùÁý´Ü
  • topological group
    À§»ó±º(êÈßÓÏØ).
  • viridans (group) streptococci
    ºñ¸®´Ü½º (¿¬¼â)±¸±Õ±º(¡­ææáðÏ¹Ð¶ÏØ).
  • zymophore group
    È¿¼ÒÀÛ¿ëÁ·(¡­íÂéÄðé).
  • accelerans substance
    ÃËÁø¹°Áú(õµòäÚªòõ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • t-Boc group
    t-Boc ±â (Ðñ)
  • thiol group
    ŸÀ̿ñâ(Ðñ)
  • tosyl group
    Åä½Ç±â(Ðñ)
  • trityl group
    Æ®¸®Æ¿±â(Ðñ)
  • Vitamin B group
    ºñŸ¹Î B ±º(ÏØ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
AMS ablepharon-microstomia syndrome; acute mountain sickness; adenosylmethionine synthetase; aggravated ...
ams amount of a substance
ANAS anastomosis; auditory nerve activating substance
AS acetylstrophanthidin; acidified serum; acoustic schwannoma; acoustic stimulation; active sarcoidosis...
ASSERT improving Alcohol and Substance abuse Services and Educating providings to Refer patients to Treatme...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
SP-IR Substance P immunoreactive
SP-IR Substance P immunoreactivity
SPLI Substance P like immunoreactivity
SPR Substance P receptor
SP-LI Substance P-like immunoreactive
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • blood sample
    Ç÷¾× Ç¥º», Ç÷¾× »ùÇÃ
  • blood serum
    Ç÷û
    1. Ç÷¾×ÀÌ ¿ÏÀüÈ÷ ÀÀ°íµÈ ´ÙÀ½ Ç÷¾×¿¡¼­ À¯¸®µÈ Åõ¸íÇÑ ¾×ü·Î, ÀÀ°í °úÁ¤¿¡ À־ Ç÷ÀåÀ¸·ÎºÎÅÍ ¼¶À¯¼Ò¿øÀÌ Á¦°ÅµÈ °Í. 2. Ç÷Àå¿¡¼­ ¼¶À¯¼Ò¿øÀ» Á¦°ÅÇÑ ³ª¸ÓÁö. »ýü¿¡¼­ äÃëÇÑ Ç÷¾×À» ½ÃÇè°ü¿¡ ³Ö¾î Á¶¿ëÈ÷ ¼¼¿öµÎ¸é ¸ÕÀú ÀÀ°íÇÏ¿© ÀÀÇ÷ÀÌ µÇ°í, À̰ÍÀÌ ¼öÃàÇÏ¿© ¾ÏÀû»öÀÇ µ¢¾î¸®ÀÎ Ç÷º´°ú ´ãȲ»öÀÇ Åõ¸íÇÑ ¾×üÀÎ Ç÷ûÀ¸·Î ³ª´©¾îÁø´Ù. Áï, Ç÷¾×¿¡¼­ À¯Çü ¼ººÐ ÀÌ¿ÜÀÇ ºÎºÐÀº Ç÷ÀåÀε¥, ÀÌ Ç÷Àå¿¡¼­ ¼¶À¯¼Ò¿ø
  • blood shadow
    Ç÷±¸¿µ
  • blood spot
    Ç÷¹Ý
  • blood stained
    ÇǼ¯ÀÎ, Çǹ¯Àº
  • blood stanching
    ÁöÇ÷
    µ¿ÀǾî=hemostasis.
  • blood stream
    Ç÷·ù
  • blood substitute
    Ç÷¾× ´ëüÁ¦
  • blood sugar
    Ç÷´ç
    Ç÷¾× ¼Ó¿¡ ÇÔÀ¯µÇ¾î ÀÖ´Â Æ÷µµ´ç. »ýü´Â ÀÚ±âÀÇ »ý¸í À¯Áö¸¦ À§ÇÏ¿© ³»Àû ȯ°æÀÇ Ç×»ó¼ºÀ» À¯ÁöÇϰí ÀÖ´Ù. Ç÷¾× ¼ÓÀÇ Æ÷µµ´ç, Áï Ç÷´çµµ Á¤»ó µ¿¿ä ¹üÀ§°¡ ºñ±³Àû Á¼¾Æ 70¡­110 mg/d§¤
  • blood sugar test
    Ç÷´ç °Ë»ç
  • blood test
    Ç÷¾× °Ë»ç, Ç÷¾× °Ë»ç¹ý
    Áúº´ÀÇ Áø´Ü, Ä¡·á ¹× ¿¹ÈÄ ÆÇÁ¤À» ¸ñÀûÀ¸·Î Ç÷¾×ÀÇ °¢Á¾ ¼ººÐÀ» °Ë»çÇÏ´Â ÀÏ. ¸ö ÀüüÀÇ Àå±â³ª Á¶Á÷¿¡ º´º¯ÀÌ ÀÖÀ¸¸é ÀÌµé ¼ººÐ¿¡ º¯È­°¡ ÀÖ°Ô µÇ¾î Áø´Ü¿¡ Å« µµ¿òÀ» ÁØ´Ù. ©ç ÇüÅÂÇÐÀû °Ë»ç¹ý : Ç÷¾×ÀÇ ¼¼Æ÷ÇÐÀû ¹× ÀÌÇÐÀûÀÎ ¼ºÁú°ú »óŸ¦ °Ë»çÇÏ´Â °ÍÀ¸·Î¼­ äÇ÷ÇÏ¿© ÀûÇ÷±¸ ¼ö, Ç÷»ö¼Ò·®, ÀûÇ÷±¸ ¿ëÀû°ú À̵鿡¼­ °è»êµÇ´Â °è¼ö¿Í ¹éÇ÷±¸ ¼ö, Ç÷¼ÒÆÇ ¼ö, ¸Á»ó ÀûÇ÷±¸ ¼ö µîÀ» °Ë»çÇÏ°í ¶Ç Ç÷¾× ÇÑ ¹æ¿ïÀ» ½½¶óÀÌµå ±Û¶ó½º¿¡ ¾ã°Ô ¹Ù¸¥ °ÍÀ» ¿°»öÇÏ¿© ¹éÇ÷±¸ÀÇ Á¾·ù, °¢Á¾ Ç÷±¸ÀÇ ÁúÀû º¯È­¸¦ Á¶»çÇÑ´Ù. ¶Ç ÃâÇ÷ ½Ã°£, ÀÀ°í ½Ã°£, ¸ð¼¼Ç÷°ü ÀúÇ× µîÀ» °Ë»çÇØ¼­ ÃâÇ÷ °æÇâ, Ç÷¾× Áúȯ, °¨¿°Áõ µîÀÇ Áø´Ü°ú °¢Á¾ ÁúȯÀÇ °æ°ú¿Í ¿¹ÈÄ ÆÇÁ¤¿¡ Å« µµ¿òÀÌ µÈ´Ù. ©è »ýÈ­ÇÐÀû °Ë»ç¹ý : Ç÷¾× ¼ÓÀÇ ¿©·¯ ¼ººÐÀ» »ýÈ­ÇÐÀû ¹æ¹ýÀ¸·Î ÃøÁ¤ÇÏ´Â °ÍÀ¸·Î Ç÷û ´Ü¹éÁú
  • blood transfusion
    ¼öÇ÷
    Ç÷¾×¿¡ Ç×ÀÀ°íÁ¦¸¦ ÷°¡ÇÑ °ÍÀ» Á¤¸Æ³»¿¡ ÁÖ»çÇÏ´Â °ÍÀ» ¸»Çϸç, º¸Åë ´Ù¸¥ »ç¶÷À¸·ÎºÎÅÍ Ã¤Ç÷ÇÑ °ÍÀ» ¼öÇ÷ÇÑ´Ù.
  • blood type
    Ç÷¾×Çü
  • blood typing
    Ç÷¾×Çü ÆÇÁ¤
  • blood vessel
    Ç÷°ü, ÇÍÁÙ
    Ç÷¾×À» ½ÉÀåÀ¸·ÎºÎÅÍ Á¶Á÷À» °ÅÃÄ ½ÉÀåÀ¸·Î µÇµ¹¾Æ¿À°Ô ÇÏ´Â ¼øÈ¯°è.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
peer group Group composed of associates of same species, approximately the same age, and usually of similar rank or social status.
(12 Dec 1998)
glycosyl group <biochemistry> A radical chemical group on a larger molecule, derived from a sugar or starch molecule, which is attached to the rest of the larger molecule by way of a glycosidic bond.
(09 Oct 1997)
C group viruses A serologic group of the genus Bunyavirus (formerly called group C arboviruses), composed of 12 species including Caraparu, Murutucu, and Oriboca virus.
(05 Mar 2000)
characterizing group A group of atoms in a molecule that distinguishes the class of substances in which it occurs from all other classes; thus carbonyl (CO) is the characterizing group of ketones; COOH, of organic acids, etc.
(05 Mar 2000)
r group <chemistry> A chemical abbreviation that normally denotes an alkyl group, but is occasionally used to refer to other organic groups.
(09 Oct 1997)
chlorine group The halogens.
(05 Mar 2000)
group 1. A cluster, crowd, or throng; an assemblage, either of persons or things, collected without any regular form or arrangement; as, a group of men or of trees; a group of isles.
2. An assemblage of objects in a certain order or relation, or having some resemblance or common characteristic; as, groups of strata.
3. <biology> A variously limited assemblage of animals or planta, having some resemblance, or common characteristics in form or structure. The term has different uses, and may be made to include certain species of a genus, or a whole genus, or certain genera, or even several orders.
4. A number of eighth, sixteenth, etc, notes joined at the stems; sometimes rather indefinitely applied to any ornament made up of a few short notes.
Origin: F groupe, It. Gruppo, groppo, cluster, bunch, packet, group; of G. Origin: cf. G. Krepf craw, crop, tumour, bunch. See Crop.
Source: Websters Dictionary
(01 Mar 1998)
group agglutination Agglutination by antibodies specific for minor (group) antigens common to several microorganisms, each of which possesses its own major specific antigen.
Synonym: cross agglutination.
(05 Mar 2000)
group agglutinin An immune agglutinin specific for a group antigen.
Synonym: cross-reacting agglutinin.
(05 Mar 2000)
group antigens Antigen's that are shared by related genera of microorganisms.
(05 Mar 2000)
group A streptococcal necrotizing fasciitis A complication of infection with GAS (group A streptococci) in which the bacteria attacks and destroys muscle tissue. According to the CDC, 5-10% of people with severe GAS infection develop necrotizing fasciitis. Though the infection can be treated with antibiotics, the fatality rate is close to 30%. This complication often develops as a wound infection after surgery or injury.
(05 Mar 2000)
group A streptococci A common bacteria that is the cause of strep throat, scarlet fever, impetigo, cellulitis-erysipelas, rheumatic fever, acute glomerular nephritis, endocarditis, and group A streptococcal necrotizing fasciitis. The prototype is Streptococcus pyogenes.
(05 Mar 2000)
group B streptococci A leading cause of a form of neonatal sepsis that has a 10-20% mortality rate and leaves a large number of survivors with brain damage. Also a leading cause of meningitis.
(05 Mar 2000)
group dynamics A term used to represent the study of underlying features of group behaviour, e.g., motives, attitudes; it is concerned with group change rather than with static characteristics.
(05 Mar 2000)
group homes Housing for groups of patients, children, or others who need or desire emotional or physical support. They are usually established as planned, single housekeeping units in residential dwellings that provide care and supervision for small groups of residents, who, although unrelated, live together as a family.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á